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Prevalence and clinical significance of stent
fracture and deformation following carotid artery
stenting
Catherine K. Chang, MD,a Chetan P. Huded, BA,b Brian W. Nolan, MD,a and
Richard J. Powell, MD,a Lebanon and Hanover, NH
Objective: Carotid artery stenting (CAS) is a developing intervention for carotid artery stenosis, and long-term outcomes
remain unclear. We examined the prevalence and clinical significance of carotid stent fractures or deformations following
CAS.
Methods: Two hundred thirty-one CAS performed in 219 patients at one academic institution between August 2000 and
March 2009 were reviewed. One hundred sixteen stents (57 closed cell, 59 open cell) were evaluated with multiplanar
plain films of the neck to assess for stent fracture or deformation. Stent fracture was identified by wire strut disruption.
Deformation was defined as an increase in stent-cell area from stent strut distortion. Study endpoints included rate of
stent fracture or deformation determined using Kaplan–Meier and life table analysis. Factors associated with stent
fracture or deformation were identified by Cox regression. Effect of stent fracture or deformation on recurrent carotid
artery stenosis >70% requiring reintervention and postoperative stroke was studied.
Results: There were five stent fractures (4%) and 27 deformed stents (23%). Rate of stent fracture or deformation was 15% at
2 years and 50% at 4 years. Deformations were significantly more common in open cell stents than in closed cell stents (58% vs
5% at 4 years, P < .00005). Presence of calcified plaque on plain film was significantly associated with increased rate of stent
fracture or deformation (P .0006). Atmedian follow-up of 25months, restenosis requiring treatment occurred in four (5%)
and late stroke in one (1%). Neither stent fracture nor deformation was associated with late stroke or reintervention.
Conclusions: Stent fracture and deformation is not uncommon following CAS and is associated with the presence of heavy
calcification. Whether a carotid stent fractures or deforms correlates with stent design. Larger studies are necessary to
determine the possible clinical significance of carotid stent fracture and deformation. (J Vasc Surg 2011;54:685-90.)
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iCarotid artery stenting (CAS) has been demonstrated
to be a viable alternative to carotid endarterectomy in the
treatment of carotid bifurcation occlusive disease in se-
lected patients. Stent fractures have been described in stents
placed in numerous arterial locations. In the setting of
stents placed in the superficial femoral artery, stent fractures
were noted in as many as a third of patients and were
associated with an increased rate of restenosis and occlu-
sion.1
Several case reports have described fractures following
carotid artery stenting.2-10 However, the incidence and
significance of carotid stent fracture is unclear. Two case
series have noted fairly disparate rates of stent fracture
following carotid artery stenting, varying between 2% and
29%.11,12 Furthermore, these studies had different conclu-
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doi:10.1016/j.jvs.2011.03.257ions regarding the clinical impact of fractures with one
bserving a higher restenosis rate in fractured stents11 and
he other noting no clinical sequelae.12 In addition to stent
racture, the potential for stent deformation without frac-
ure also exists, and the incidence and clinical impact of
tent deformation is also unknown.
The purpose of this study was to examine the incidence
f stent fracture and/or deformation following carotid
rtery stent placement and to determine the effect of these
tent changes on clinical outcomes. In addition, potential
atient specific and anatomic factors that may be associated
ith stent fracture and/or deformation were evaluated.
ETHODS
This study was approved by the Institutional Review
oard. Charts from all patients undergoing CAS placement
t Dartmouth Hitchcock Medical Center between 2000
nd 2009 were reviewed. The degree of carotid artery
tenosis was evaluated preoperatively in all patients by
arotid duplex ultrasound. This was confirmed with further
maging by computed tomographic angiography (CTA).
symptomatic patients underwent carotid artery stenting if
emonstrated to have 80% stenosis by duplex criteria.
ymptomatic patients were treated if demonstrated to have
50% stenosis by duplex criteria. Patients who were found
n preprocedure CTA to have a type III aortic arch, severe
nternal carotid artery tortuosity, or circumferential calcifi-
ation of the internal carotid artery did not undergo CAS.
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September 2011686 Chang et alCarotid artery stenting was performed under local an-
esthesia with minimal or no sedation. All patients were
started on aspirin and clopidogrel at least 3 days prior to the
procedure if the patient was not already taking these anti-
platelet medications. All carotid artery stents were placed
percutaneously via femoral artery access while fully antico-
agulated with heparin. An embolic protection device was
used in every patient. All carotid lesions were predilated and
then postdilated following placement of the stent. Seven
different self-expanding stents and one balloon expandable
stent were utilized with both open cell and closed cell
designs. All patients were admitted for neurologic observa-
tion for at least 24 hours. The majority of patients were
examined independently pre- and postprocedure by a neu-
rologist. All patients were entered into investigational de-
vice exemption approved clinical CAS trials in a sequential
manner and as such there was no selection bias based on
type of stent placed. Follow-up consisted of a carotid
duplex on postprocedure day 1, 1 month, 6 months and
then yearly thereafter. Patients with elevated peak systolic
velocities postprocedure correlating with50% re-stenosis
were followed more closely with a duplex every 6 months.
Two hundred thirty-one carotid artery stents were
placed in 219 patients between 2000 and 2009. There were
41 deaths (19%) in this cohort during up to 9 years of
follow-up. Of the remaining 189 stents in 178 patients still
alive at the time of the study, 116 stents in 109 patients
(61%) were available for further evaluation withmultiplanar
plain films of the neck to assess for stent changes. A surveil-
Fig 1. Example of carotidlance protocol for carotid stent fracture was put into place ror all patients available for follow-up. All patients under-
ent an initial neck x-ray either at the first subsequent
ollow-up visit for patients with previously placed stents or
t 1 month for patients receiving initial carotid stents. All
atients underwent neck x-ray on a yearly basis. Among this
ubset, patient demographic information, including age,
ender, preoperative medications, and medical comorbidi-
ies were reviewed. Data regarding procedural details were
lso collected in addition to each patient’s clinical course
ostprocedure, both in-hospital and during long-term
ollow-up. Patients were considered to have in-stent carotid
rtery restenosis if duplex criteria demonstrated a 70% ste-
osis (peak systolic velocity 340 cm/s). No patient under-
ent reintervention if duplex showed70% stenosis.
High resolution digital images of the multiplanar plain
lms of the neck were assessed for the presence of stent
racture or deformation by two independent vascular sur-
eons. Stent fracture was defined as an observed break in
tent struts. Fractures ranged from involving a single stent
trut to a complete linear break in the stent with associated
isplacement (Fig 1). Stent deformation was defined as an
ncrease of 100% or more in stent cell area (Fig 2). Ob-
erved agreement between the reviewers was 97% with a 
f 0.93 (95% confidence intervals [CI] .86-1.00). In addi-
ion, each stent was evaluated for the presence of carotid
rtery calcification. This was defined as a calcified plaque
isible on plain film (Fig 3). Observed agreement on the
resence of calcification was 100% ( 1.0). The effect of
tent fracture or deformation on death, stroke, and carotid
y stent fractures at arrows.estenosis was evaluated.
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Volume 54, Number 3 Chang et al 687All statistical analysis was performed using Stata 9.0
software (StataCorp, College Station, Tex). Incidence of
stent fracture and deformation was determined at 2 and 4
years following the procedure using Fisher exact test, two-
Fig 2. Example of carotid ar
Fig 3. Example of calcification seen on plain film in the
Xact stent on right).tailed. Statistical significance was inferred at P  .05. pESULTS
One hundred sixteen stents placed in 109 patients were
valuated with multiplanar plain films of the neck among
32 total stents placed between 2000 and 2009. The
tent deformations at arrows.
nce of stent fracture or deformation (Wallstent on left,abseatient demographics and procedural details of this subset
y
p
C
(
r
y
o
t
a
a
s
o
g
t

s
d
o
s
v
c
C
d
a
d
m
D
a
a
t
a
t
C
t
a
s
a
d
f
T
O
C
a
JOURNAL OF VASCULAR SURGERY
September 2011688 Chang et alare shown in Table I. Mean patient age was 69  9 years
(range 50-91). Most patients were male (70%) and the
presence of cardiovascular risk factors, coronary artery dis-
ease, and peripheral vascular disease was common. The
majority of patients had asymptomatic carotid artery disease
(63%). Amongst patients with symptoms, most (70%) pre-
sented with transient ischemic attacks, including both
monocular blindness and hemispheric symptoms, rather
than stroke. Contralateral internal carotid artery occlusion
was present in 13% of cases. The median follow-up was 25
months with a range of 1 to 82 months (interquartile range
18-47 months).
Approximately half (49%) of the carotid stents placed
were of the closed cell stent design. Of these, the majority
were Xact stents (n  41, Abbott Vascular, Santa Clara,
Calif). The remaining closed cell stents were mostly Wall-
stents (n  14, Boston Scientific Corporation, Natick,
Mass) but also included one Cypher (Cordis Corporation,
Bridgewater, NJ) and one Nexstent (Boston Scientific Cor-
poration).
Of the open cell stents placed, 26 (44%) were Acculink
stents (Abbott Vascular), 17 (29%) were Vivexx stents
(Bard Peripheral Vascular, Tempe, Ariz), 15 (25%) were
Precise stents (Cordis Corporation), and one was an Ex-
press stent (Boston Scientific Corporation).
The 30-day combined stroke and death rate in the
study patients was 0.9%.
There were five fractures (4%) and 27 deformations
(23%). The combined rate of stent fracture or deformation
was 15% at 2 years and 50% at 4 years.
Only one open cell stent (Vivexx) fractured. The other
four fractures all occurred in closed cell Xact stents. No
Wallstents fractured despite a longer median follow-up
time of 4.9 years compared with 1.5 years for Xact stents.
The type of closed cell stent was significantly associated
with stent fracture (P  .011) (Table II).
Deformations were significantly more common in open
Table I. Patient and procedural characteristics
Patient characteristics
Patient demographics
Age (years, mean  SD) 69  9
Male 81 (70%)
Patient comorbidities
Hypertension 96 (83%)
Dyslipidemia 97 (84%)
Diabetes 35 (30%)
Coronary artery disease 70 (60%)
Peripheral vascular disease 61 (53%)
Current smoking 61 (53%)
Procedural characteristics
Side of stenting
Right 57 (49%)
Ipsilateral symptoms 43 (37%)
TIA 30 (70%)
Stroke 13 (30%)
Contralateral ICA occlusion 15 (13%)
ICA, Internal carotid artery; TIA, transient ischemic attack.cell stents compared with closed cell stents (58% vs 5% at 4 bears, P  .0001). When data were analyzed on a per
atient basis there was no change in the findings. Univariate
ox regression analysis demonstrated a hazards ratio of 28
95% CI 4-213) associated with open cell stent design and
isk of stent deformation (P  .001).
The incidence of stent fracture or deformation at 4
ears in the presence of calcified plaque on plain film
ccurred in 62% of stents compared with 15% incidence in
he absence of calcification (P  .0001). A Cox regression
nalysis demonstrated a hazards ratio of 6 (95% CI 2-20)
ssociated with calcification seen on plain film and risk of
tent fracture or deformation for all stents, including both
pen and closed cell designs (P  .003).
There was no association between severity of stenosis or
ender and carotid stent fracture/deformation.
Five patients underwent reintervention for carotid ar-
ery in-stent re-stenosis (defined as peak systolic velocity
340 cm/s or 70% stenosis). All five were open cell
tents. Of these five stents, one was found to be significantly
eformed. The other four stents had no associated fracture
r deformation. Neither stent fracture nor deformation was
ignificantly associated with re-stenosis requiring reinter-
ention or neurologic complications.
One patient presented with stroke 4 years following
arotid artery stent placement. Upon evaluation with both
TA and plain films, she was found to have a severely
eformed stent. CTA also demonstrated thrombus associ-
ted with the stent changes. She underwent excision of the
eformed carotid artery stent and reconstruction with a 6
m polytetrafluoroethylene (PTFE) interposition graft.
ISCUSSION
Carotid artery stenting has been studied extensively,
nd recent studies have reported CAS to be a reasonable
lternative to CEA even in good risk patients.13 The latest
rial is CREST, amulticenter trial in which both asymptom-
tic and symptomatic good risk patients were randomized
o either carotid artery stenting or carotid endarterectomy.
REST found no significant difference in the occurrence of
he primary endpoint composed of 30 day death, stroke,
nd myocardial infarction (MI) plus 4-year ipsilateral
troke. The investigators concluded that CAS is a reason-
ble alternative to CEA in treating carotid bifurcation
isease for conventional risk patients.14
Of concern, however, are the recent reports of stent
ractures discovered within stents placed into the carotid
able II. Fractures and stent cell design
Stents
 1 years Fractures (%)
Median
F/U (years)
pen cell stents 53 1 (2%) 2.4
losed cell stents 41 4 1.8
Xact 27 4 (15%)a 1.5
Wallstent 12 0 (0%)a 4.9
Type of stent was significantly associated with stent fracture (P  .011).ifurcation. In addition to isolated case reports, two com-
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Volume 54, Number 3 Chang et al 689parable sized studies had examined the prevalence of stent
fractures following carotid artery stenting. Ling et al re-
ported a carotid stent fracture prevalence of 29% in 48
stents and also observed a higher restenosis rate of 21% in
fractured stents compared with 9% in stents without frac-
ture.11 In contrast, Varcoe et al described a fracture rate of
2% in 51 carotid stents and noted no clinical sequelae.12
Ling et al did not address stent deformation at all. How-
ever, Varcoe et al noted that 11% of carotid stents had
developed an irregular “fish-scale” appearance that could
be confused for fracture. Whether these stent changes were
associated with restenosis or symptoms was not reported.12
Our series, which is the largest to date, underscores the
not insignificant incidence of stent fracture and/or defor-
mation following carotid bifurcation stenting, approaching
a combined rate of 50% at 4 years. The prevalence of stent
fracture in our series was observed to be 4% and that of stent
deformation to be 23%. These measurements tend to cor-
roborate the rates noted in the two published series in
which carotid stent changes were common, ranging from
13% to 29%.11,12
The development of either stent fracture or deforma-
tion was found in our series to be approximately six times
more common in the setting of highly calcified carotid
arteries, as reflected by easily visible calcification on plain
films of the neck (P .003). This relationship is consistent
with that reported by Ling et al. That study in which Xact
(Abbott, Abbott Park, Ill), Precise (Cordis, Miami Lakes,
Fla), and Exponent (Medtronic Vascular, Santa Rosa,
Calif) stents were inserted observed that the presence of
carotid artery calcification on plain film was associated with
nearly an 8 fold increase in the odds of stent fracture.11 A
correlation between extensive calcification and a higher rate
of fracture had also previously been demonstrated in coro-
nary stents.15 An increased susceptibility to stent fracture or
deformation may result from a combination of the repeti-
tive mechanical forces present in these arteries along with
stent compression resulting from severe calcification. Vos et
al demonstrated that considerable torsion shear and angu-
lation of the carotid artery occurs with head movement
following carotid artery stenting.16 The association be-
tween highly calcified carotid arteries and an increased rate
of stent complications underscores the importance of CT
angiography prior to carotid artery stenting. We have pre-
viously reported the utility of preprocedure 3D CT angiog-
raphy to assess the degree of carotid bifurcation calcifica-
tion prior to CAS.17
Stent fractures following CAS were significantly associ-
ated with a closed cell stent design and a specific stent type.
Of the five observed fractures, only one occurred in an open
cell stent. The remaining four all occurred in closed cell
Xact stents, with a rate of 15% amongst stents older than 1
year. Ling et al noted a similarly high Xact stent fracture rate
of 24% (8 of 34).11 No Wallstents were observed to be
fractured in our series despite a longer median follow-up
time. This difference may be attributable to the distinct
flexibility and torsional strength of the various stents which
are available. These properties were studied in several avail- mble carotid stents by Vos et al who noted Wallstents in
articular to have greater than average flexibility and tor-
ional strength.18 Xact stents were not examined in that
eries.
While prior studies have examined carotid stent frac-
ures in some detail, significant stent deformation in the
bsence of an observed stent strut break has not been
ddressed. In the current study, stent deformations oc-
urred more frequently than stent fractures. In addition,
tent deformations were significantly more common in
pen cell stents compared with closed cell stents (HR 28,
 .001). This finding is consistent with the 11% stent
hanges “that could be confused for fracture” reported by
arcoe et al, as 92% of the stents placed in that series were
pen cell stents.12 Open cell stents have a lower density of
truts and generally larger free cell areas compared with
losed cell stents. Thus, open cell stents are thought to be
ore flexible and to conform better to angulated and
rregular vessels. However, Vos et al found the measured
exibility of carotid stents to decrease following deploy-
ent in the carotid artery irrespective of the flexibility in the
x vivo state.18 In the setting of stent compression due to a
eavily calcified plaque, repetitive mechanical forces may
esult in bending of the stent struts and significant stent
eformation over time. In accordance with this, our study
ound both open cell stent design and the presence of heavy
alcification to be independent predictors of stent deforma-
ion.
Of the 116 stents followed in this cohort, only five
tents required reintervention for restenosis of 70%.
one of the patients had associated neurologic symptoms.
nterestingly, all of the recurrent stenosis occurred in open
ell stents.
Of the 32 stent fractures and deformations observed in
his study, one deformed stent was associated with a signif-
cant restenosis which required reintervention and another
as associated with late stroke (the only late stroke in the
ntire cohort). The remaining 30 other stent changes were
ot associated with neurologic symptoms or restenosis.
here was no evidence of significant clinical impact of stent
racture or deformation on either re-stenosis or neurologic
omplications. However, given the low rate of reinterven-
ion and stroke in this series, a less robust clinical impact
annot be accurately assessed.
Another limitation of this study is the possibility of
election bias. Only 116 stents were evaluated in follow-up
ith multiplanar plain films of the neck amongst a total of
31 carotid bifurcation stents placed. This could allow for
election bias to significantly influence the measured rate of
tent fracture and deformation. Thirty-nine percent of sur-
iving patients were lost to follow-up, and 19% of patients
ied before this study was conducted. Amongst this group,
plausible cause is occult stroke that may have been asso-
iated with stent fracture or deformation. Thus, the inci-
ence of stent fracture or deformation is likely higher in
hese patients who died or were lost to follow-up than that
easured in this study. Selection bias is more likely to lead
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and/or deformation rather than the reverse.
Assessments of calcification and stent fracture/
deformation were not independent, thus, bias could exist in
both measurements. Attempts to mitigate this bias in-
cluded having two reviewers evaluate the neck films.
Though concordance between the reviewers was high fu-
ture studies should quantitatively assess the degree of cal-
cification prior to carotid stent placement.
In conclusion, the rate of stent fracture and deforma-
tion has only been studied in relatively small case cohort
studies. However, all suggest that the rate of stent fracture
and deformation is substantial. These stent changes are
related to patient specific anatomy, stent cell design, and
stent type. Whether these stent changes over time are
clinically significant, and the potential magnitude of that
clinical impact, remain understudied and warrant larger
cohort studies to address these concerns.
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